Bened Life Targets Longevity Market with New Cognitive Probiotic

FREMONT, CA – December 01, 2025 – In a move that highlights the convergence of biotechnology and the burgeoning wellness market, Bened Life has announced the launch of Neuralli® Cognition+, a new probiotic supplement aimed at adults aged 50 and older. The product launch is more than just an expansion of the company’s portfolio; it represents a significant strategic pivot into the highly competitive and rapidly growing healthy aging sector, leveraging the increasingly sophisticated science of the gut-brain axis.

Neuralli® Cognition+ is formulated to support short-term memory, cognitive function, and muscle strength, addressing three key concerns for the aging demographic. By doing so, Bened Life is betting on a new frontier in consumer health: one where specific, clinically studied microbial strains are seen not just as aids for digestion, but as essential tools for maintaining cognitive and physical vitality throughout life. This launch solidifies the company's position as a key player translating complex microbiome research into accessible consumer products.

The Science Behind the Strategic Shift

The foundation of Neuralli® Cognition+ rests on two specific probiotic strains, Bifidobacterium breve MCC1274 and Lacticaseibacillus paracasei PS23™, which Bened Life holds exclusive rights to in the United States. This exclusivity is a critical component of the company's market strategy, creating a moat around its formulation in a crowded field. The decision to focus on just two strains underscores a shift away from generic, multi-strain blends toward targeted, evidence-based interventions.

Research underpins the company's claims. Seven peer-reviewed studies on the individual strains form the scientific backbone of the product. Studies on B. breve MCC1274, often associated with its developer Morinaga Milk Industry, have shown promising results in older adults. One randomized, double-blind, placebo-controlled trial found that subjects concerned about forgetfulness showed significant improvements in immediate and delayed memory scores. Another study suggested the strain could even suppress the progression of brain atrophy in individuals with mild cognitive impairment, pointing to a potential preventative role.

Meanwhile, L. paracasei PS23™, a strain linked to research from Bened Biomedical, has demonstrated benefits in both preclinical cognitive studies and human trials related to physical performance. While its cognitive benefits in older adults are still being explored in an ongoing open-label trial, separate studies have shown it can help prevent strength loss and accelerate muscle recovery. This dual-action potential—addressing both mind and body—is a key differentiator and reflects a holistic approach to the challenges of aging.

While much of the supporting research is connected to the strains' developers, a common practice in the specialized nutraceutical industry, the publication in peer-reviewed journals provides a level of scientific validation that many competitors lack. This commitment to evidence is central to Bened Life's brand identity.

A Calculated Play for the Longevity Economy

The launch of Neuralli® Cognition+ is a well-timed entry into the global longevity market. With the world's population aged 60 and over growing rapidly, consumer demand for products that support healthy aging has skyrocketed. This demographic is increasingly proactive, educated, and willing to invest in non-pharmaceutical solutions to maintain their quality of life, independence, and cognitive sharpness.

The cognitive health supplements market, in particular, is experiencing substantial growth. Bened Life's move taps directly into this trend, offering a solution that aligns with consumer desires for natural, science-backed alternatives to traditional pharmaceuticals. The company's CEO, Franklin Cheng, framed the launch as a key advancement in their mission.

"Neuralli® Cognition+ is an important milestone in our mission to advance gut-brain science into accessible, evidence-informed products," Cheng stated in the official announcement. "The clinical data supporting the strains in this formulation make it a compelling option for adults seeking to support cognition and short-term memory as they age."

This statement encapsulates the company’s strategy: leveraging robust scientific data to build consumer trust and capture a significant share of a market driven by health anxieties and aspirations. By positioning the product for pre-sale months ahead of its February 2026 shipment date, Bened Life is also building market anticipation and gauging initial demand for its premium offering.

Differentiating in a Crowded Wellness Aisle

Bened Life is not the first company to offer a probiotic for brain health, but its strategy for Neuralli® Cognition+ reveals a nuanced understanding of the competitive landscape. Instead of creating a supplement with a long list of vitamins, herbal extracts, and generic probiotic strains, the company has focused on the unique, combined benefits of its exclusive strains.

The pairing of a cognitive-focused strain (B. breve MCC1274) with one that also shows promise for muscle strength (L. paracasei PS23™) is a distinctive approach. It addresses the interconnected nature of aging, where maintaining physical strength is crucial for preventing falls, preserving mobility, and supporting overall independence—factors that are deeply intertwined with mental well-being and quality of life. This holistic messaging resonates with consumers who are looking for comprehensive solutions rather than single-issue pills.

This product complements Bened Life's existing line, which includes Neuralli® MP for neurological conditions and Neuralli® Mood for stress support, demonstrating a coherent and expanding ecosystem of gut-brain products. This portfolio approach reinforces the company's expertise and builds a brand identity centered on targeted neurological and cognitive health through the microbiome. As the wellness industry continues to mature, companies that can successfully carve out a specialized, science-backed niche are the ones most likely to achieve sustained growth and command consumer loyalty.